Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic acid metabolism and UGT/CYP gene polymorphism correlation study in epilepsy
ChiCTR-RCH-14005080Phase 4Recruiting
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of valproic acid in epilepsy (2 arms), sponsored by Xiangya Hospital, Central South University. Primary endpoints: Valproic acid concentration, Metabolite concentration and 3 more. Started Aug 2012; status: recruiting.
02
Drugs
valproic acid
03
Conditions
epilepsy
Beyond the preview
Go deeper on ChiCTR-RCH-14005080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-RCH-14005080.